SPOTLIGHT -
Slideshow
Author(s):
Treatment failure risk is high, new biomarker of conversion from major depressive disorder, depression stifles creativity, and other recent findings are summarized here.
Investigating the SAINT iTBS Protocol for Bipolar I Depression
Blue Light, Depression, and Bipolar Disorder
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia
Four Myths About Lamotrigine
BHV-7000 for Bipolar Disorder Fails in Phase 2/3 Trial
Agree to Disagree: A Collaborative Perspective From a Treatment Team and Disagreeing Patient